However, a key distinction we make here is that LSD1 suppresses thousands of enhancers in ES cells, while TRIM33 preferentially accumulates at a small number of regulatory elements in the B-ALL genome. The gene discussed is TRIM33; the disease is acute lymphoblastic leukemia.